Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
Objective Sodium glucose cotransporter-2 inhibitors (SGLT2i) exert cardiorenal protection in people with diabetes. By inducing glycosuria, SGLT2i predispose to genital infections. In addition, rare occurrence of Fournier’s gangrene (FG) has been reported. We aimed to investigate such association thr...
Saved in:
| Main Authors: | Gian Paolo Fadini, Mayur Sarangdhar, Angelo Avogaro, Emanuel Raschi, Fabrizio De Ponti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/7/1/e000725.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fournier's gangrene
by: Milović Novak, et al.
Published: (2008-01-01) -
Genital reconstruction and urethral plasty after Fournier?s gangrene and urethral fistula
by: Hugo Rivera-Astorga, et al.
Published: (2025-07-01) -
Fournier′s gangrene of the penis
by: Francis Leo Tauro, et al.
Published: (2005-07-01) -
TREATMENT OF PATIENTS WITH GANGRENE FOURNIER
by: O. B. Priyma
Published: (2017-02-01) -
Fournier's Gangrene: Skin Grafting
by: R. C. Yadav, et al.
Published: (1980-07-01)